Showing results 1 to 20 of 59
next >
| Issue Date | Title | Author(s) |
| 2024-09-07 | Different Models, Same Results: Considerations When Choosing Between Approaches to Model Cost Effectiveness of Chimeric-Antigen Receptor T-Cell Therapy Versus Standard of Care. | Gye, A; De Abreu Lourenco, R; Goodall, S |
| 2024-08 | Patient preferences for investigating cancer-related symptoms in Australian general practice: a discrete-choice experiment. | Venning, B; Pearce, A; De Abreu Lourenco, R; Hall, R; Bergin, RJ; Lee, A; Donohoe, K; Emery, J |
| 2024-06 | What are the cost and resource implications of voluntary assisted dying and euthanasia? | Hudson, P; Marco, D; De Abreu Lourenco, R; Philip, J |
| 2024-01 | Use of Health Technology Assessment for the Continued Funding of Health Technologies: The Case of Immunoglobulins for the Management of Multifocal Motor Neuropathy. | Vargas, C; Addo, R; Lewandowska, M; Haywood, P; De Abreu Lourenco, R; Goodall, S |
| 2023-12-06 | Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer. | Buteau, JP; Moon, D; Fahey, MT; Roberts, MJ; Thompson, J; Murphy, DG; Papa, N; Mitchell, C; De Abreu Lourenco, R; Dhillon, HM; Kasivisvanathan, V; Francis, RJ; Stricker, P; Agrawal, S; O'Brien, J; McVey, A; Sharma, G; Levy, S; Ayati, N; Nguyen, A; Lee, S-F; Pattison, DA; Sivaratnam, D; Frydenberg, M; Du, Y; Titus, J; Lee, S-T; Ischia, J; Jack, G; Hofman, MS; Emmett, L |
| 2023-12 | If we do not count it, it does not count: ethnicity in allogeneic haemopoietic stem cell transplant in Australia. | McErlean, G; Bajel, A; Bhattacharyya, A; Brown, N; De Abreu Lourenco, R; Greenwood, M; Kerridge, I; Kim, N; Kliman, D; Maneze, D; O'Brien, T; Szer, J; Twist, I |
| 2023-12 | SCORE: a randomised controlled trial evaluating shared care (general practitioner and oncologist) follow-up compared to usual oncologist follow-up for survivors of colorectal cancer. | Jefford, M; Emery, JD; James Martin, A; De Abreu Lourenco, R; Lisy, K; Grunfeld, E; Mohamed, MA; King, D; Tebbutt, NC; Lee, M; Mehrnejad, A; Burgess, A; Marker, J; Eggins, R; Carrello, J; Thomas, H; Schofield, P |
| 2023-08-04 | [18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial. | Koh, E-S; Gan, HK; Senko, C; Francis, RJ; Ebert, M; Lee, ST; Lau, E; Khasraw, M; Nowak, AK; Bailey, DL; Moffat, BA; Fitt, G; Hicks, RJ; Coffey, R; Verhaak, R; Walsh, KM; Barnes, EH; De Abreu Lourenco, R; Rosenthal, M; Adda, L; Foroudi, F; Lasocki, A; Moore, A; Thomas, PA; Roach, P; Back, M; Leonard, R; Scott, AM |
| 2023-06-14 | A systematic review of economic evaluations for RPE65-mediated inherited retinal disease including HTA assessment of broader value. | Farris, M; Goodall, S; De Abreu Lourenco, R |
| 2023-02-01 | Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors. | Goldstein, DA; Ginsberg, GM; Hofnung-Gabbay, D; De Abreu Lourenco, R; Loong, HH; Goh, BC; Chan, KKW; Di Maio, M; Perrone, F; Hall, PS; Zer, A; Rosenbaum, E |
| 2023-02-01 | SCORE: A multisite randomised controlled trial evaluating shared care for colorectal cancer survivors. | Jefford, M; Emery, JD; Martin, AJ; De Abreu Lourenco, R; Lisy, K; Mohamed, MA; King, D; Tebbutt, NC; Lee, M; Mehrnejad, A; Burgess, A; Marker, J; Eggins, R; Carrello, J; Schofield, P |
| 2023-01 | Men's perceptions and preferences regarding prostate cancer radiation therapy: A systematic scoping review. | Brown, A; Yim, J; Jones, S; Tan, A; Callander, E; Watt, K; De Abreu Lourenco, R; Pain, T |
| 2022-12 | Perceptions and recall of treatment for prostate cancer: A survey of two populations. | Brown, A; Tan, A; Anable, L; Callander, E; De Abreu Lourenco, R; Pain, T |
| 2022-10-21 | Cost-effectiveness Analysis of Tisagenlecleucel Versus Blinatumomab in Children and Young Adults with Acute Lymphoblastic Leukemia: Partitioned Survival Model to Assess the Impact of an Outcome-Based Payment Arrangement. | Gye, A; Goodall, S; De Abreu Lourenco, R |
| 2022-10 | Preferences for a polygenic test to estimate cancer risk in a general Australian population. | Venning, B; Saya, S; De Abreu Lourenco, R; Street, DJ; Emery, JD |
| 2022-10 | The Effects of Multimodal Prehabilitation Interventions in Men Affected by Prostate Cancer on Physical, Clinical and Patient Reported Outcome Measures: A Systematic Review. | Paterson, C; Roberts, C; Kozlovskaia, M; Nahon, I; Schubach, K; Sara, S; Sayner, AM; De Abreu Lourenco, R; Turner, M; Chan, RJ; Lam, T; Woo, H; Toohey, K |
| 2022-09 | TROG 14.04: Multicentre Study of Feasibility and Impact on Anxiety of DIBH in Breast Cancer Patients. | Kron, T; Bressel, M; Lonski, P; Hill, C; Mercieca-Bebber, R; Ahern, V; Lehman, M; Johnson, C; Latty, D; Ward, R; Miller, D; Banjade, D; Morriss, D; De Abreu Lourenco, R; Woodcock, J; Montgomery, R; Lehmann, J; Chua, BH |
| 2022-04-19 | Surveillance Improves Outcomes for Carriers of SDHB Pathogenic Variants: A Multicenter Study. | Davidoff, DF; Benn, DE; Field, M; Crook, A; Robinson, BG; Tucker, K; De Abreu Lourenco, R; Burgess, JR; Clifton-Bligh, RJ |
| 2022-01-01 | Family, healthcare professional, and societal preferences for the treatment of infantile spinal muscular atrophy: a discrete choice experiment. | Carey, KA; Farrar, MA; Kasparian, NA; Street, DJ; De Abreu Lourenco, R |
| 2022-01-01 | Men's preferences for image-guidance in prostate radiation therapy: A discrete choice experiment. | Brown, A; Pain, T; Tan, A; Anable, L; Callander, E; Watt, K; Street, D; De Abreu Lourenco, R |
